Browse studies, page 971
Page 971 of 1,287, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia The Journal of infectious diseases, 2004
- A controlled trial of a critical pathway for treating community-acquired pneumonia: the CAPITAL study. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin Pharmacotherapy, 2001
- Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial The Lancet. Infectious diseases, 2019
- A liquid chromatography-tandem mass spectrometry assay for the determination of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, in human plasma and urine and its application to a single-dose pharmacokinetic study in healthy Chinese volunteers Biomedical chromatography : BMC, 2012
- A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial Current medical research and opinion, 2008
- Impact of gemifloxacin on the normal human intestinal microflora Journal of chemotherapy (Florence, Italy), 2001
- Levofloxacin versus beta-lactamic therapy in community acquired pneumonia that requires hospitalization Anales de medicina interna (Madrid, Spain : 1984), 2002
- Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: effects of treatment with a beta-lactam versus a fluoroquinolone Antimicrobial agents and chemotherapy, 2008
- Which Nursing Home Residents With Pneumonia Are Managed On-Site and Which Are Hospitalized? Results from 2 Years' Surveillance in 14 US Homes Journal of the American Medical Directors Association, 2020
- Pharmacokinetics of levofloxacin in healthy Thai male volunteers Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1999
- Clinical Investigations: INFECTIONA Cost-Minimization Analysis Comparing Azithromycin-Based and Levofloxacin-Based Protocols for the Treatment of Patients Hospitalized With Community-Acquired Pneumonia: Results From the CAP-IN Trial Chest, 2005
- Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults Chest, 2004
- An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia The American journal of managed care, 2000
- Acute Pericarditis due to Coxiellaburnetiiinfection, a case report 2018
- Clinical significance of nosocomial Cryptococcus laurentii in urine: A case series Infection control and hospital epidemiology, 2019
- Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics International Journal of Molecular Sciences, 2021
- Safety of oral nemonoxacin: A systematic review of clinical trials and postmarketing surveillance Frontiers in Pharmacology, 2022
- Risk Factors for Acquired Stenotrophomonas maltophilia Pneumonia in Intensive Care Unit: A Systematic Review and Meta-Analysis Frontiers in medicine, 2021
- Oligella spp.: A systematic review on an uncommon urinary pathogen European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2024
- Do fluoroquinolones increase aortic aneurysm or dissection incidence and mortality? A systematic review and meta-analysis Frontiers in cardiovascular medicine, 2022
- Progress on implementing the WHO-GLASS recommendations on priority pathogen-antibiotic sensitivity testing in Africa: A scoping review Wellcome open research, 2024
- Antibiotics for chronic pulmonary infection in children with a neurodisability (neurodevelopmental disorder) The Cochrane database of systematic reviews, 2023
- GATA2 deficiency and hemophagocytic lymphohistiocytosis (HLH): a systematic review of reported cases BMC infectious diseases, 2024
- Antibiotic Resistance during COVID-19: A Systematic Review International journal of environmental research and public health, 2022
- Awareness of Microbiological Safety in Playgrounds Amid Rising Antibiotic Resistance Environmental microbiology reports, 2025
- Prevalence and Etiology of Community- and Hospital-Acquired Pneumonia in Saudi Arabia and Their Antimicrobial Susceptibility Patterns: A Systematic Review Medicina (Kaunas, Lithuania), 2023
- Global challenges of bacterial infections in organ transplantation: assessment of risk factors and predominant bacterial pathogen profiles threatening liver, kidney, heart, and lung transplant recipients BMC infectious diseases, 2025
- Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review Vaccine, 2017
- Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis Clinical Therapeutics, 2008
- Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia American Journal of Health-System Pharmacy, 2000
- An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia PubMed, 2007
- Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia Current Medical Research and Opinion, 2004
- Clinical and economic burden of community-acquired pneumonia among adults in Europe Thorax, 2010
- A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin JAMA, 2000
- Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired Pneumonia in adults Antimicrobial Agents and Chemotherapy, 2005
- Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia BMC Infectious Diseases, 2005
- Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin Clinical Therapeutics, 2000
- FRI0374 the risk of infection by tumor necrosis factor inhibitors and its associated factors in patients with ankylosing spondylitis: result from korean national health insurance data Spondyloarthritis – treatment, 2019
- Cavitation DUE to COVID-19: a case of secondary atypical mycobacterial infection post-COVID-19 Chest, 2021
- 2577. Comparing Omadacycline with Existing Antibiotics in the treatment of Acute Bacterial Infections: A Systematic Review Open Forum Infectious Diseases, 2023
- Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 Lancet. Infectious Diseases (Print), 2022
- Antibiotic-Resistant Bacteria in Intensive Care Units in the Kingdom of Saudi Arabia: A Systematic Review Middle East Journal of Nursing, 2024
- Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet. Infectious Diseases (Print), 2026
- Sensitivity of <>iStreptococcus pneumoniae to antibiotics and the sex of the patient: A systematic review and meta-analysis Epidemiology and Infectious Diseases, 2022
- Top 20 Research Studies of 2024 for Primary Care Physicians American Family Physician, 2025
- Thrombosis risk associated with COVID-19 infection. A scoping review Thrombosis research, 2020
- Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19 Alimentary pharmacology & therapeutics, 2020
- A systematic review and meta-analysis of data on pregnant women with confirmed COVID-19: Clinical presentation, and pregnancy and perinatal outcomes based on COVID-19 severity Journal of global health, 2021
- Co-infections in people with COVID-19: a systematic review and meta-analysis The Journal of infection, 2020
- Respiratory tract infections and gut microbiome modifications: A systematic review PloS one, 2022
- Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis Journal of clinical laboratory analysis, 2022
- Type 2 diabetes mellitus and antibiotic-resistant infections: a systematic review and meta-analysis Journal of epidemiology and community health, 2022
- Klebsiella pneumoniae: an increasing threat to public health Annals of clinical microbiology and antimicrobials, 2020
- Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021) Antimicrobial resistance and infection control, 2022
- Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis Scientific reports, 2021
- Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021
- Prevalence of self-medication during COVID-19 pandemic: A systematic review and meta-analysis Frontiers in public health, 2022
- The prevalence of colistin resistance in clinical Stenotrophomonas maltophilia isolates worldwide: a systematic review and meta-analysis BMC microbiology, 2023
- Incidence and predictors of mortality among persons receiving second-line tuberculosis treatment in sub-Saharan Africa: A meta-analysis of 43 cohort studies PloS one, 2021
- Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis Infectious diseases of poverty, 2023
- Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis BMC infectious diseases, 2023
- Antimicrobial resistance in wild game mammals: a glimpse into the contamination of wild habitats in a systematic review and meta-analysis BMC veterinary research, 2025
- Extended-spectrum β-lactamase production and antimicrobial resistance among Enterobacteriaceae causing clinical infections in Africa: a systematic review and meta-analysis (2012-2020) European journal of medical research, 2025
- Non-prescription antibiotic use and its predictors among children in low- and middle-income countries: a systematic review and meta-analysis Italian journal of pediatrics, 2024
- Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia in Patients with Hematologic Malignancies-A Systematic Review and Meta-Analysis Medicina (Kaunas, Lithuania), 2024
- First global report about the prevalence of multi-drug resistant Haemophilus influenzae: a systematic review and meta-analysis BMC infectious diseases, 2024
- Antimicrobial prescription pattern and appropriateness for respiratory tract infection in outpatients: a systematic review and meta-analysis Systematic reviews, 2024
- A systematic review and meta-analysis show a decreasing prevalence of post-stroke infections BMC neurology, 2024
- Risk factors for drug-resistant pathogens in community-acquired pneumonia: systematic review and meta-analysis European respiratory review : an official journal of the European Respiratory Society, 2025
- Prevalence and Phenotypic Antimicrobial Resistance of Listeria monocytogenes from Animal-Derived Foods: A Scoping Review Foods (Basel, Switzerland), 2026
- Programming Hydrogel Release Kinetics to Tissue Healing Phases: From Network Design to Therapeutic Synchronization Gels (Basel, Switzerland), 2026
- Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV. Viruses, 2020
- Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations Journal of chemotherapy (Florence, Italy), 2014
- In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae The Journal of antimicrobial chemotherapy, 1999
- Preparation of a thermosensitive and antibacterial in situ gel using poloxamer-quaternized chitosan for sustained ocular delivery of Levofloxacin hydrochloride International journal of biological macromolecules, 2024
- In vitro antituberculous activity of ofloxacin and levofloxacin against multidrug-resistant tuberculosis and clinical outcomes Kekkaku : [Tuberculosis], 2006
- Precision Formulation of Ocular Films for Eye Infections using Innovative Quality by Design Optimization Drug metabolism and bioanalysis letters, 2024
- Strain-to-strain variability among Staphylococcus aureus causing prosthetic joint infection drives heterogeneity in response to levofloxacin and rifampicin The Journal of antimicrobial chemotherapy, 2022
- Pharmacokinetic/pharmacodynamic comparison between generic and brand-name levofloxacin based on Monte Carlo simulation Journal of global antimicrobial resistance, 2023
- In vitro activities of levofloxacin and comparable agents against middle ear fluid, nasopharyngeal, and oropharyngeal pathogens obtained from Costa Rican children with recurrent otitis media or failing other antibiotic therapy Antimicrobial agents and chemotherapy, 2005
- Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa International journal of antimicrobial agents, 2005
- Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosis Antimicrobial agents and chemotherapy, 2016
- Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, 'Israeli spotted fever group rickettsia' and Coxiella burnetii The Journal of antimicrobial chemotherapy, 1997
- Levofloxacin: serum bactericidal activity against methicillin-resistant Staphylococcus aureus isolates The Journal of antimicrobial chemotherapy, 1999
- Delamanid Kills Dormant Mycobacteria In Vitro and in a Guinea Pig Model of Tuberculosis Antimicrobial agents and chemotherapy, 2017
- Combination Effect of Cefuroxime and Levofloxacin Against Bacteria Isolated from the Healthy Conjunctival Sac and Endophthalmitis Cases Using a Fractional Inhibitory Concentration Index Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2017
- Formulation and Development of Nanofiber-Based Ophthalmic Insert for the Treatment of Bacterial Conjunctivitis International journal of molecular sciences, 2024
- Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus Antimicrobial agents and chemotherapy, 1997
- Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa Chemotherapy, 2009
- Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients International journal of antimicrobial agents, 2002
- In Vitro Activities of the Benzoquinolizine Fluoroquinolone Levonadifloxacin (WCK 771) and Other Antimicrobial Agents against Mycoplasmas and Ureaplasmas in Humans, Including Isolates with Defined Resistance Mechanisms Antimicrobial agents and chemotherapy, 2018
- In vitro activities of garenoxacin and levofloxacin against Chlamydia pneumoniae are not affected by presence of Mycoplasma DNA. Antimicrobial agents and chemotherapy, 2004
- Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates Antimicrobial agents and chemotherapy, 1995
- Interactions of fluoroquinolone antibacterials, DX-619 and levofloxacin, with creatinine transport by renal organic cation transporter hOCT2 Drug metabolism and pharmacokinetics, 2006
- In vitro susceptibilities of bacterial isolates from conjunctival flora to gatifloxacin, levofloxacin, tosufloxacin, and moxifloxacin Eye & contact lens, 2008
- Comparative study of antimicrobial release kinetics from polymethylmethacrylate Clinical orthopaedics and related research, 2006
- In Vitro Activities of Ceftaroline and Comparators against Streptococcus pneumoniae Isolates from U.S. Hospitals: Results from Seven Years of the AWARE Surveillance Program (2010 to 2016) Antimicrobial agents and chemotherapy, 2018
- The changes of ocular bacterial isolates and in vitro antimicrobial susceptibility in the past six years [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 2012
- Effect of aluminium ion on bioavailability of levofloxacin following oral administration of cilexetil ester of levofloxacin as prodrug in rats Die Pharmazie, 2020
- In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin Diagnostic microbiology and infectious disease, 1997
